![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
| Medicamento usado para tratar la infección por hepatitis C. También está en estudio para el tratamiento y la prevención del cáncer. Es una citocina modificada en el laboratorio. Es un tipo de modificador de la respuesta biológica. También se llama PEG-interferón alfa-2b y SCH 54031. |
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081011094407im_/http://www.nci.nih.gov/images/spacer.gif) |